Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$840,740
+$181,203 QoQ
Shares Held
147,240
+23.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 216 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. ANNX ranks #140 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in ANNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $840,740 | 147,240 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $659,537 | 119,050 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $706,514 | 140,740 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $429,257 | 140,740 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $337,776 | 140,740 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $214,809 | 111,300 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $570,969 | 111,300 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $753,971 | 127,360 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $717,605 | 146,450 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $291,245 | 40,620 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $184,414 | 40,620 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $95,863 | 40,620 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $142,982 | 40,620 | Shares | Defined | 2023-08-15 | |
| 2022-03-31 | $6,780,364 | 2,483,650 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $24,018,178 | 2,090,355 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,958,599 | 1,717,281 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $35,960,242 | 1,597,523 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $40,288,795 | 1,447,155 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $28,421,014 | 1,135,478 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $29,607,927 | 979,422 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||